Akebia Therapeutics | AKBA - Cost Of Sales


Akebia Therapeutics reported $10.34M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 24.79M 1.43M Mar/2026
Agios Pharmaceuticals USD 1.32M 560K Mar/2026
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alnylam Pharmaceuticals USD 211.12M 56.6M Mar/2026
Amgen USD 1.6B 187M Mar/2026
Ardelyx USD 4.81M 6.04M Mar/2026
Astellas Pharma JPY 129.43B 19.7B Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 5.23B 731M Mar/2026
BioMarin Pharmaceutical USD 199.48M 37.93M Mar/2026
Celltrion KRW 92.83B 14.59B Mar/2026
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Exelixis USD 19.95M 6.53M Mar/2026
Fresenius Medical Care EUR 3.43B 248M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Ionis Pharmaceuticals USD 3M 5M Mar/2026
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
J&J USD 8B 67M Jun/2026
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Karyopharm Therapeutics USD 1.48M 35.95M Dec/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Lexicon Pharmaceuticals USD 201K 191K Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Moderna USD 955M 503M Mar/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organigram Holdings CAD 43.39M 13.54M Mar/2026
Pharma Mar EUR 3.66M 116K Mar/2026
Prothena USD 28.94M 11.58M Sep/2025
PTC Therapeutics USD 39.61M 23.31M Mar/2026
Qiagen NV USD 182.72M 34.71M Mar/2026
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.67B 621M Mar/2026
Sarepta Therapeutics USD 109.46M 289.93M Mar/2026
Sartorius EUR 478.7M 5.9M Jun/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Tilray USD 164.37M 8.41M Sep/2025
Vanda Pharmaceuticals USD 198.77M 151.12M Dec/2024
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026